Your browser doesn't support javascript.
loading
A review of the pharmacokinetics, efficacy and safety of high-purity factor X for the prophylactic treatment of hereditary factor X deficiency.
Payne, Jeanette; Batsuli, Glaivy; Leavitt, Andrew D; Mathias, Mary; McGuinn, Catherine E.
Afiliación
  • Payne J; Department of Paediatric Haematology, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
  • Batsuli G; Department of Pediatrics, Division of Pediatric Hematology and Oncology, Emory University, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
  • Leavitt AD; Departments of Laboratory Medicine & Medicine (Hematology), University of California San Francisco, San Francisco, California, USA.
  • Mathias M; Great Ormond Street Hospital for Children NHS Foundation Trust, Haemophilia Comprehensive Care Centre, London, UK.
  • McGuinn CE; Department of Pediatrics, Division of Pediatric Hematology Oncology, Weill Cornell Medicine, New York, New York, USA.
Haemophilia ; 28(4): 523-531, 2022 Jul.
Article en En | MEDLINE | ID: mdl-35499465
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factor X / Deficiencia del Factor X Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Humans Idioma: En Revista: Haemophilia Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factor X / Deficiencia del Factor X Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adolescent / Adult / Child / Humans Idioma: En Revista: Haemophilia Asunto de la revista: HEMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido